Cargando…

Melanoma: From Research to Treatment

Detalles Bibliográficos
Autores principales:	Ascierto, Paolo A., Kirkwood, John M., Marincola, Francesco M., Palmieri, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337615/ https://www.ncbi.nlm.nih.gov/pubmed/22570789 http://dx.doi.org/10.1155/2011/710697

Ejemplares similares

What is changing in the adjuvant treatment of melanoma?
por: Ascierto, Paolo A., et al.
Publicado: (2017)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Combination therapy: the next opportunity and challenge of medicine
por: Ascierto, Paolo A, et al.
Publicado: (2011)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
por: Ascierto, Paolo A, et al.
Publicado: (2008)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment
por: Ascierto, Paolo A, et al.
Publicado: (2010)

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5(th)–6 (th)2011”
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6(th)-7 (th)2010"
por: Ascierto, Paolo A, et al.
Publicado: (2011)

NF-κB as potential target in the treatment of melanoma
por: Madonna, Gabriele, et al.
Publicado: (2012)

Melanoma: the role of surgery in the era of new therapies
por: Mozzillo, Nicola, et al.
Publicado: (2014)

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
por: Galon, Jerome, et al.
Publicado: (2017)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013
por: Ascierto, Paolo A, et al.
Publicado: (2014)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

Lean oncology: a new model for oncologists
por: Montesarchio, Vincenzo, et al.
Publicado: (2012)

The immune‐related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2014)

The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015)

In support of descriptive studies; relevance to translational research
por: Marincola, Francesco M
Publicado: (2007)

New paradigm for stage III melanoma: from surgery to adjuvant treatment
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

Preserving a legacy for our patients: The bedside-to-bench award in translational research
por: Marincola, Francesco M
Publicado: (2008)

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
por: Ascierto, Paolo A, et al.
Publicado: (2013)

Main roads to melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2009)

Correction to: New paradigm for stage III melanoma: from surgery to adjuvant treatment
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

The immune score as a new possible approach for the classification of cancer
por: Galon, Jérôme, et al.
Publicado: (2012)

How scientists use social media to communicate their research
por: Van Eperen, Laura, et al.
Publicado: (2011)

Biotechnology entrepreneurship - where no research has gone before
por: Salgaller, Michael L, et al.
Publicado: (2010)

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2018)

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2019)

Editorial: Combination Strategies in the Treatment of Melanoma
por: Ascierto, Paolo Antonio
Publicado: (2016)

Rewarding patient-directed research: Excellence in Translational Medicine Award
por: Brander, Christian, et al.
Publicado: (2006)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014
por: Ascierto, Paolo A., et al.
Publicado: (2015)

Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015
por: Ascierto, Paolo A., et al.
Publicado: (2016)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations
por: Gentilcore, Giusy, et al.
Publicado: (2013)

Issues affecting molecular staging in the management of patients with melanoma
por: Palmieri, G, et al.
Publicado: (2007)

Create a translational medicine knowledge repository - Research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?
por: Littman, Bruce H, et al.
Publicado: (2011)

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”
por: Ascierto, Paolo A, et al.
Publicado: (2013)

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2015)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sktrgkfevhqfpibebamujok4cb